Back
RBC Target 2027 Canadian Corp BondIdxETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
87
RQP.TO
RBC Target 2027 Canadian Corp BondIdxETF
Last Price:
18.29
Seasonality Move:
-0.98%
Buy
72
ALGS
Aligos Therapeutics
Last Price:
33.28
Seasonality Move:
10.65%
Buy
87
RBC Target 2027 Canadian Corp BondIdxETF (RQP.TO)
is a Buy
Is RBC Target 2027 Canadian Corp BondIdxETF a Buy, Sell or Hold?
- The current RBC Target 2027 Canadian Corp BondIdxETF [RQP.TO] share price is $18.29. The Score for RQP.TO is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- RQP.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
72
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $33.11. The Score for ALGS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RQP.TO Stock Price Chart
What is RBC Target 2027 Canadian Corp BondIdxETF's stock price today?
-
The RBC Target 2027 Canadian Corp BondIdxETF share price today is $18.29
The current trend is moderately bullish and RQP.TO is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $33.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
RQP.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 58.71 | Buy |
| Chaikin Money Flow: | -5988 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.16 - 18.28) | Buy |
| Bollinger Bands (100): | (18.09 - 18.27) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.85 | Buy |
| Relative Strength Index (14 RSI): | 78.88 | Buy |
| Chaikin Money Flow: | -127407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.12 - 28.52) | Buy |
| Bollinger Bands (100): | (7.57 - 20.11) | Buy |
RQP.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.29 | Sell |
| 20-day SMA: | 18.22 | Buy |
| 50-day SMA: | 18.22 | Buy |
| 200-day SMA: | 17.95 | Buy |
| 8-day EMA: | 18.29 | Buy |
| 20-day EMA: | 18.25 | Buy |
| 50-day EMA: | 18.22 | Buy |
| 200-day EMA: | 17.98 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.4 | Buy |
| 20-day SMA: | 24.33 | Buy |
| 50-day SMA: | 15.25 | Buy |
| 200-day SMA: | 15.91 | Buy |
| 8-day EMA: | 29.74 | Buy |
| 20-day EMA: | 24.86 | Buy |
| 50-day EMA: | 18.75 | Buy |
| 200-day EMA: | 16.3 | Buy |
RBC Target 2027 Canadian Corp BondIdxETF Earnings Growth & RQP.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
RBC Target 2027 Canadian Corp BondIdxETF Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||